Congratulations to our colleague, Dr. Rafaela Andrade, co-founder and CEO of Halifax-based company Myomar Molecular on their Mitacs Outstanding Entrepreneur Award!!
Dr. Andrade has used Atlantic PATH data and biosamples in their project, Clinical Study and Identification of Muscle Atrophy Biomarkers.
Dr. Andrade and Myomar Molecular’s work have developed the world’s first urine strip test for measuring muscle loss. Ultimately, this work will allow for early monitoring of indicators of muscle loss and early interventions and improved quality of life.